ERBB4 and cancer: The prognostic value of ERBB4 was an independent external validation in the cohort [TMB and Immunotherapy (MSKCC, Nat Genet 2019)] (Samstein et al. 2019) in cBioPortal of Cancer Genomics, according to the analysis herein.